1. Home
  2. HROW vs RES Comparison

HROW vs RES Comparison

Compare HROW & RES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • RES
  • Stock Information
  • Founded
  • HROW 1998
  • RES 1984
  • Country
  • HROW United States
  • RES United States
  • Employees
  • HROW N/A
  • RES N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • RES Oilfield Services/Equipment
  • Sector
  • HROW Health Care
  • RES Energy
  • Exchange
  • HROW Nasdaq
  • RES Nasdaq
  • Market Cap
  • HROW 1.1B
  • RES 1.1B
  • IPO Year
  • HROW N/A
  • RES N/A
  • Fundamental
  • Price
  • HROW $30.66
  • RES $5.15
  • Analyst Decision
  • HROW Strong Buy
  • RES Hold
  • Analyst Count
  • HROW 6
  • RES 3
  • Target Price
  • HROW $59.00
  • RES $5.75
  • AVG Volume (30 Days)
  • HROW 433.0K
  • RES 1.4M
  • Earning Date
  • HROW 08-06-2025
  • RES 07-24-2025
  • Dividend Yield
  • HROW N/A
  • RES 3.10%
  • EPS Growth
  • HROW N/A
  • RES N/A
  • EPS
  • HROW N/A
  • RES 0.35
  • Revenue
  • HROW $212,858,000.00
  • RES $1,370,043,000.00
  • Revenue This Year
  • HROW $44.92
  • RES $16.54
  • Revenue Next Year
  • HROW $38.12
  • RES $11.28
  • P/E Ratio
  • HROW N/A
  • RES $14.62
  • Revenue Growth
  • HROW 53.49
  • RES N/A
  • 52 Week Low
  • HROW $19.31
  • RES $4.10
  • 52 Week High
  • HROW $59.23
  • RES $7.54
  • Technical
  • Relative Strength Index (RSI)
  • HROW 57.58
  • RES 62.24
  • Support Level
  • HROW $30.01
  • RES $4.80
  • Resistance Level
  • HROW $31.63
  • RES $5.06
  • Average True Range (ATR)
  • HROW 1.59
  • RES 0.18
  • MACD
  • HROW 0.02
  • RES 0.07
  • Stochastic Oscillator
  • HROW 66.10
  • RES 82.78

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About RES RPC Inc.

RPC Inc is an oilfield services company. It provides specialized oilfield services and equipment to independent and oil and gas companies engaged in the exploration, production, and development of oil and gas properties throughout the United States. The company's operating segment includes Technical Services and Support Services. It generates maximum revenue from the Technical Services segment. Technical Services segment nclude RPC's oil and gas services that utilize people and equipment to perform value-added completion, production and maintenance services directly to a customer's well. Support Services segment consists of drill pipe and related tools, pipe handling, pipe inspection and storage services, and oilfield training and consulting services.

Share on Social Networks: